{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:07:41Z","timestamp":1761581261114},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["semradonc.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.semradonc.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T17:51:39Z","timestamp":1418665899000},"page":"133-142","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Evolving Role of Molecular Imaging in Non\u2013Small Cell Lung Cancer Radiotherapy"],"prefix":"10.1016","volume":"25","author":[{"given":"Michael","family":"MacManus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Everitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney J.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2014.12.001_bib1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1183\/09031936.01.17408020","article-title":"The role of positron emission tomography with 18F-fluoro-2-deoxy-d-glucose in respiratory oncology","volume":"17","author":"Vansteenkiste","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semradonc.2014.12.001_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.radonc.2006.09.011","article-title":"Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non\u2013small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives","volume":"81","author":"Nestle","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib3","first-page":"68S","article-title":"PET-based treatment planning in radiotherapy: A new standard?","volume":"48","author":"Gregoire","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0360-3016(01)01824-7","article-title":"The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non\u2013small-cell lung carcinoma: A prospective study","volume":"52","author":"Mah","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-642-59349-9_19","article-title":"Molecular whole-body cancer staging using positron emission tomography: Consequences for therapeutic management and metabolic radiation treatment planning","volume":"162","author":"Schmucking","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.semradonc.2014.12.001_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0360-3016(03)00346-8","article-title":"Radiation treatment planning with an integrated positron emission and computer tomography (PET\/CT): A feasibility study","volume":"57","author":"Ciernik","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijrobp.2009.06.032","article-title":"Reproducibility of \u201cintelligent\u201d contouring of gross tumor volume in non\u2013small-cell lung cancer on PET\/CT images using a standardized visual method","volume":"77","author":"Bayne","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1378\/chest.119.3.950","article-title":"Positron emission tomography in the staging of small-cell lung cancer: A preliminary study","volume":"119","author":"Hauber","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.semradonc.2014.12.001_bib9","first-page":"1911","article-title":"Whole-body 18F-FDG PET improves the management of patients with small cell lung cancer","volume":"44","author":"Kamel","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00259-002-0937-8","article-title":"Prognostic value of [18F]FDG-PET imaging in small cell lung cancer","volume":"30","author":"Pandit","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.coc.0000054889.58718.6F","article-title":"Impact of positron emission tomography on the management of patients with small-cell lung cancer: Preliminary experience","volume":"27","author":"Blum","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/annonc\/mdl374","article-title":"A prospective study of PET\/CT in initial staging of small-cell lung cancer: Comparison with CT, bone scintigraphy and bone marrow analysis","volume":"18","author":"Fischer","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11307-009-0295-z","article-title":"High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer","volume":"12","author":"Azad","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/RLU.0b013e318251e3d1","article-title":"Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET\/CT in non\u2013small cell lung cancer","volume":"37","author":"Lasnon","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0030-1270799","article-title":"Prognosis in patients with non\u2013small cell lung cancer and satellite tumors","volume":"59","author":"Kocaturk","year":"2011","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.semradonc.2014.12.001_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.athoracsur.2008.11.073","article-title":"Surgical resection is justified in non\u2013small cell lung cancer patients with node negative T4 satellite lesions","volume":"87","author":"Pennathur","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.semradonc.2014.12.001_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00259-005-1901-1","article-title":"PET recognition of pulmonary metastases on PET\/CT imaging: Impact of attenuation-corrected and non\u2013attenuation-corrected PET images","volume":"33","author":"Reinhardt","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.7326\/0003-4819-139-11-200311180-00013","article-title":"Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non\u2013small-cell lung cancer: A meta-analysis","volume":"139","author":"Gould","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib19","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/cncr.22518","article-title":"Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET\/CT in a tuberculosis-endemic country: Diagnostic efficacy in 674 patients","volume":"109","author":"Kim","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2014.12.001_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1095-0397(00)00096-0","article-title":"Follow-up of patients with single pulmonary nodules and negative 18F-fluorodeoxyglucose positron emission tomography scans","volume":"3","author":"Abou-Zied","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5694\/j.1326-5377.2001.tb143587.x","article-title":"Positron emission tomography in pulmonary masses where tissue diagnosis is unhelpful or not possible","volume":"175","author":"Pitman","year":"2001","journal-title":"Med J Aust"},{"key":"10.1016\/j.semradonc.2014.12.001_bib22","first-page":"3837","article-title":"Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography","volume":"6","author":"Vesselle","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2014.12.001_bib23","first-page":"1426","article-title":"Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG","volume":"44","author":"Buck","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/RCT.0b013e3180980db9","article-title":"3\u2032-Deoxy-3\u2032-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumors: Comparison with 2-deoxy-2-18F-fluoro-d-glucose","volume":"32","author":"Yamamoto","year":"2008","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.semradonc.2014.12.001_bib25","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00259-004-1552-7","article-title":"The performance of 18F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules","volume":"31","author":"Herder","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00259-002-1055-3","article-title":"PET-CT: Accuracy of PET and CT spatial registration of lung lesions","volume":"30","author":"Cohade","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib27","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1120\/jacmp.v12i4.3502","article-title":"Motion artifacts occurring at the lung\/diaphragm interface using 4D CT attenuation correction of 4D PET scans","volume":"12","author":"Killoran","year":"2011","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s00259-002-0853-y","article-title":"FDG-PET imaging in lung cancer: How sensitive is it for bronchioloalveolar carcinoma?","volume":"29","author":"Yap","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib29","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2967\/jnumed.108.052712","article-title":"Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET\/CT","volume":"49","author":"Goudarzi","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2967\/jnumed.112.104380","article-title":"The utility of 18F-FDG PET\/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis","volume":"53","author":"Sobic-Saranovic","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0169-5002(02)00023-5","article-title":"FDG-PET imaging and the diagnosis of non\u2013small cell lung cancer in a region of high histoplasmosis prevalence","volume":"36","author":"Croft","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semradonc.2014.12.001_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiology.216.1.r00jl19117","article-title":"Pulmonary tuberculoma evaluated by means of FDG PET: Findings in 10 cases","volume":"216","author":"Goo","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2014.12.001_bib33","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2010.30.0731","article-title":"Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non\u2013small-cell lung cancer: A population-based time-trend analysis","volume":"28","author":"Palma","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib34","first-page":"30","article-title":"18F-FDG PET in candidates for radiation therapy: Is it important and how do we validate its impact?","volume":"44","author":"Hicks","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.13-2924","article-title":"When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis","volume":"146","author":"Louie","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.semradonc.2014.12.001_bib36","doi-asserted-by":"crossref","first-page":"157S","DOI":"10.1378\/chest.123.1_suppl.157S","article-title":"Invasive staging of non\u2013small cell lung cancer: A review of the current evidence","volume":"123","author":"Toloza","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.semradonc.2014.12.001_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiology.191.2.8153308","article-title":"Staging of mediastinal non\u2013small cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation","volume":"191","author":"Wahl","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2014.12.001_bib38","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1378\/chest.112.6.1480","article-title":"Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non\u2013small cell lung cancer: A prospective analysis of 50 cases","volume":"112","author":"Vansteenkiste","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.semradonc.2014.12.001_bib39","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1148\/radiology.213.2.r99nv46530","article-title":"Metastases from non\u2013small cell lung cancer: Mediastinal staging in the 1990s\u2014Meta-analytic comparison of PET and CT","volume":"213","author":"Dwamena","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2014.12.001_bib40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2214\/AJR.05.2081","article-title":"Efficacy of helical dynamic CT versus integrated PET\/CT for detection of mediastinal nodal metastasis in non\u2013small cell lung cancer","volume":"188","author":"Yi","year":"2007","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1183\/09031936.00044612","article-title":"Radial probe EBUS versus CT-guided needle biopsy for evaluation of peripheral pulmonary lesions: An economic analysis","volume":"41","author":"Steinfort","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semradonc.2014.12.001_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1445-5994.2008.01670.x","article-title":"Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non\u2013small-cell lung cancer","volume":"38","author":"Kalade","year":"2008","journal-title":"Intern Med J"},{"key":"10.1016\/j.semradonc.2014.12.001_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0360-3016(01)01477-8","article-title":"High rate of detection of unsuspected distant metastases by pet in apparent stage III non\u2013small-cell lung cancer: Implications for radical radiation therapy","volume":"50","author":"MacManus","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2001-16201","article-title":"Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000","volume":"55","author":"Hellwig","year":"2001","journal-title":"Pneumologie"},{"key":"10.1016\/j.semradonc.2014.12.001_bib45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2214\/ajr.168.5.9129444","article-title":"Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography","volume":"168","author":"Erasmus","year":"1997","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib46","first-page":"1795","article-title":"18F-FDG PET in characterizing adrenal lesions detected on CT or MRI","volume":"42","author":"Yun","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib47","first-page":"2058","article-title":"18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer","volume":"45","author":"Kumar","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4149\/neo_2010_02_129","article-title":"18F-FDG PET\/CT in the evaluation of adrenal masses in lung cancer patients","volume":"57","author":"Lu","year":"2010","journal-title":"Neoplasma"},{"key":"10.1016\/j.semradonc.2014.12.001_bib49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MNM.0b013e32834199e7","article-title":"The role of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiating between benign and malignant adrenal lesions","volume":"32","author":"Ozcan Kara","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.semradonc.2014.12.001_bib50","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s002590050291","article-title":"Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non\u2013small cell lung cancer","volume":"25","author":"Bury","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1095-0397(00)00048-0","article-title":"Comparison of FDG-PET and bone scans for detecting skeletal metastases in patients with non\u2013small cell lung cancer","volume":"3","author":"Durski","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1536-1632(03)00036-2","article-title":"Comparison of bone and 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in the evaluation of bony metastases in lung cancer","volume":"5","author":"Gayed","year":"2003","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/0891060310002230","article-title":"FDG-PET-detected extracranial metastasis in patients with non\u2013small cell lung cancer undergoing staging for surgery or radical radiotherapy\u2014Survival correlates with metastatic disease burden","volume":"42","author":"MacManus","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib54","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1148\/radiol.2292021598","article-title":"Non\u2013small cell lung cancer: Dual-modality PET\/CT in preoperative staging","volume":"229","author":"Antoch","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2014.12.001_bib55","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1183\/09031936.00119106","article-title":"Detection of extrapulmonary lesions with integrated PET\/CT in the staging of lung cancer","volume":"29","author":"De Wever","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semradonc.2014.12.001_bib56","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1148\/radiol.2252011568","article-title":"PET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results","volume":"225","author":"Hany","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2014.12.001_bib57","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00259-002-0902-6","article-title":"Brown adipose tissue: A factor to consider in symmetrical tracer uptake in the neck and upper chest region","volume":"29","author":"Hany","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.semnuclmed.2007.01.001","article-title":"Increased 18F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography\/computed tomography (PET\/CT): Accumulated data from four years of experience with PET\/CT","volume":"37","author":"Metser","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib59","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/1097-0142(20010815)92:4<886::AID-CNCR1397>3.0.CO;2-V","article-title":"F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: Powerful correlation with survival and high impact on treatment","volume":"92","author":"MacManus","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2014.12.001_bib60","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(02)03046-8","article-title":"Failure of T stage to predict survival in patients with non\u2013small-cell lung cancer treated by radiotherapy with or without concomitant chemotherapy","volume":"54","author":"Ball","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib61","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2010.04.018","article-title":"Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non\u2013small-cell lung cancer: A prospective study","volume":"80","author":"Kolodziejczyk","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib62","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s00259-002-0801-x","article-title":"FDG PET for staging of advanced non\u2013small cell lung cancer prior to neoadjuvant radio-chemotherapy","volume":"29","author":"Eschmann","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib63","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.radonc.2012.12.018","article-title":"The use of fused PET\/CT images for patient selection and radical radiotherapy target volume definition in patients with non\u2013small cell lung cancer: Results of a prospective study with mature survival data","volume":"106","author":"MacManus","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2967\/jnmt.108.059584","article-title":"Economic evaluation of PET and PET\/CT in oncology: Evidence and methodologic approaches","volume":"38","author":"Buck","year":"2010","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib65","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1002\/cncr.25392","article-title":"High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography\/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer","volume":"116","author":"Everitt","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2014.12.001_bib66","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2013.02.010","article-title":"The impact of time between staging PET\/CT and definitive chemo-radiation on target volumes and survival in patients with non\u2013small cell lung cancer","volume":"106","author":"Everitt","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib67","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2967\/jnumed.111.092544","article-title":"18F-FDG PET as a surrogate biomarker in non\u2013small cell lung cancer treated with erlotinib: Newly identified lesions are more informative than standardized uptake value","volume":"53","author":"Bengtsson","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"Berghmans","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib69","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.acra.2011.12.010","article-title":"Baseline SUVmax at PET-CT in stage IIIA non\u2013small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: Prognostic implication focused on histopathologic subtypes","volume":"19","author":"Lee","year":"2012","journal-title":"Acad Radiol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib70","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2013.10.029","volume":"88","author":"Nair","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib71","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2012.04.019","article-title":"Stereotactic body radiotherapy (SBRT) for non\u2013small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?","volume":"104","author":"Clarke","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib72","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.radonc.2011.08.008","article-title":"The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non\u2013small-cell lung cancer after stereotactic body radiotherapy (SBRT)","volume":"101","author":"Takeda","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib73","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/JTO.0000000000000185","article-title":"Primary tumor standardized uptake value measured on F18-fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non\u2013small-cell lung cancer receiving radiotherapy: Meta-analysis","volume":"9","author":"Na","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/JTO.0000000000000096","article-title":"Absence of a relationship between tumor 18F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non\u2013small-cell lung cancer","volume":"9","author":"Lin","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib75","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ijrobp.2008.12.039","article-title":"Imaging cellular proliferation during chemo-radiotherapy: A pilot study of serial 18F-FLT positron emission tomography\/computed tomography imaging for non\u2013small-cell lung cancer","volume":"75","author":"Everitt","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib76","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: Adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib77","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semradonc.2014.12.001_bib78","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1200\/JCO.2005.05.2878","volume":"24","author":"Rischin","year":"2006","journal-title":"J Clin Onco"},{"key":"10.1016\/j.semradonc.2014.12.001_bib79","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00259-009-1154-5","article-title":"Initial results of hypoxia imaging using 1-\u03b1-d: -(5-Deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA)","volume":"36","author":"Postema","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib80","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/1754-9485.12086","article-title":"Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non\u2013small cell lung cancer treated with definitive chemoradiotherapy","volume":"57","author":"Trinkaus","year":"2013","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib81","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2008.11.008","article-title":"Use of PET and PET\/CT for radiation therapy planning: IAEA expert report 2006-2007","volume":"91","author":"MacManus","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib82","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0360-3016(01)01722-9","article-title":"Observer variation in contouring gross tumor volume in patients with poorly defined non\u2013small-cell lung tumors on CT: The impact of 18FDG-hybrid PET fusion","volume":"51","author":"Caldwell","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib83","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2003.10.044","article-title":"Impact of FDG-PET on radiation therapy volume delineation in non\u2013small-cell lung cancer","volume":"59","author":"Bradley","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib84","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2005.04.021","article-title":"The contribution of integrated PET\/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer","volume":"63","author":"Ashamalla","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib85","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2005.05.016","article-title":"Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non\u2013small-cell lung cancer","volume":"63","author":"Deniaud-Alexandre","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib86","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00259-006-0252-x","article-title":"Target volume definition for 18F-FDG PET\u2013positive lymph nodes in radiotherapy of patients with non\u2013small cell lung cancer","volume":"34","author":"Nestle","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2014.12.001_bib87","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ijrobp.2009.09.060","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography\u2013based radiotherapy target volume definition in non\u2013small-cell lung cancer: Delineation by radiation oncologists vs. joint outlining with a PET radiologist?","volume":"78","author":"Hanna","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib88","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2010.04.018","article-title":"Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non\u2013small-cell lung cancer: A prospective study","volume":"80","author":"Kolodziejczyk","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2010.09.033","article-title":"A phase II comparative study of gross tumor volume definition with or without PET\/CT fusion in dosimetric planning for non\u2013small-cell lung cancer (NSCLC): Primary analysis of Radiation Therapy Oncology Group (RTOG) 0515","volume":"82","author":"Bradley","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib90","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0360-3016(99)00061-9","article-title":"18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis","volume":"44","author":"Nestle","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib91","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijrobp.2006.12.067","article-title":"PET-CT\u2013based auto-contouring in non\u2013small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes","volume":"68","author":"van Baardwijk","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib92","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1118\/1.1809778","article-title":"Four-dimensional (4D) PET\/CT imaging of the thorax","volume":"31","author":"Nehmeh","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib93","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.ijrobp.2010.12.060","article-title":"Clinical utility of 4D FDG-PET\/CT scans in radiation treatment planning","volume":"82","author":"Aristophanous","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib94","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13246-011-0109-x","article-title":"Motion effects on SUV and lesion volume in 3D and 4D PET scanning","volume":"34","author":"Callahan","year":"2011","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib95","doi-asserted-by":"crossref","first-page":"N259","DOI":"10.1088\/0031-9155\/53\/13\/N03","article-title":"Attenuation correction of four dimensional (4D) PET using phase-correlated 4D-computed tomography","volume":"53","author":"Ponisch","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib96","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.2003.07.054","article-title":"Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non\u2013small-cell lung cancer","volume":"21","author":"MacManus","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2008.05.004","article-title":"Additional PET\/CT in week 5-6 of radiotherapy for patients with stage III non\u2013small cell lung cancer as a means of dose escalation planning?","volume":"88","author":"Gillham","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib98","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ijrobp.2007.11.049","article-title":"Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: A prospective study","volume":"71","author":"Aerts","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2014.12.001_bib99","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2967\/jnumed.111.102566","article-title":"Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non\u2013small cell lung cancer","volume":"53","author":"van Elmpt","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2014.12.001_bib100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2012.03.005","article-title":"The PET-boost randomised phase II dose-escalation trial in non\u2013small cell lung cancer","volume":"104","author":"van Elmpt","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2014.12.001_bib101","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2004.11.024","article-title":"Metabolic (FDG-PET) response after radical radiotherapy\/chemoradiotherapy for non\u2013small cell lung cancer correlates with patterns of failure","volume":"49","author":"MacManus","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semradonc.2014.12.001_bib102","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2967\/jnumed.113.131631","article-title":"Differential 18F-FDG and 18F-FLT uptake on serial PET\/CT imaging before and during definitive chemoradiation for non\u2013small cell lung cancer","volume":"55","author":"Everitt","year":"2014","journal-title":"J Nucl Med"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429614001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429614001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T23:12:19Z","timestamp":1598569939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429614001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1053429614001179"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2014.12.001","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Evolving Role of Molecular Imaging in Non\u2013Small Cell Lung Cancer Radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}